ketamine-nightmares

Anaesthesia Final Exam

Document Summaries

ANZCA Position Statements

** High yield **

• PS03 2014: Regional Anaesthesia
• PS09 2014: Sedation
• PS12 2014: Smoking
• PS15 2018: Day Surgery
• PS18 2017: Monitoring
• PS26 2005: Consent
• PS28 2015: Infection Control
• PS29 2019: Paediatric Anaesthesia
• PS52 2015: Transport
• PS55 2012: Minimum safe facilities
• PS63 2019: Acute behavioural disturbance

** Low yield - clinical **

• PS04 2018: Recovery Unit
• PS06 2019: Anaesthesia record
• PS07 2021: Pre-anaesthesia consult
• PS19 2020: Monitored Care
• PS27 2015: Major Extracorporeal Perfusion
• PS31 2014: Anaesthesia Machine Check
• PS37 2013: Local Anaesthesia
• PS46 2014: Periop cardiac ultrasound
• PS51 2017: Medication Safety
• PS53 2013: Handover
• PS54 2013: Anaesthesia workstation
• PS56 2021: Difficult airway equipment
• PS60 2015: Chlorhexidine hypersensitivity
• PS61 2016: CICO

** Low yield - organisational **

• PS01 2010: GP Anaesthetist Training
• PS08 2016: Anaesthesia assistant
• PS02 2018: Credentialling
• PS40 2012: Health Industry
• PS41 2013: Acute Pain Management
• PS42 2017: Department Staffing
• PS43 2019: Fatigue
• PS45 2010: Patients’ rights
• PS49 2010: Doctors’ health
• PS50 2017: Return to practice
• PS57 2014: Anaesthetists’ duties
• PS58 2018: Quality assurance and quality improvement
• PS59 2015: Anaesthetists’ periop responsibilities
• PS62 2016: Cultural competence
• PS64 2019: Environmental sustainability
• PS65 2018: Peer performance assessment

FPM Position Statements

• PM01 2020: Opioids
• PM10 2019: Cannabis
• PM11 2019: Procedures
• PM12 2021: Ketamine
• PMXX 2018: OIVI